-
RESTRICT-seq Maps Epigenetic Dependencies in SCC
2026-08-25
The bioRxiv preprint introduces RESTRICT-seq, a time-gated CRISPR screening framework designed to resolve when genetic perturbations become important during squamous cell carcinoma resistance. Its findings support a dynamic view of resistance biology in which epigenetic dependencies may be missed by conventional endpoint screens, with implications for mechanistic validation and therapeutic timing.
-
Sulfo-Cy3 NHS Ester in Vascular Translation
2026-08-25
A mechanistic and translational perspective on using Sulfo-Cy3 NHS Ester to interrogate the AIBP–LRP2–HDL–miR-223 axis and CXCR4-positive endothelial remodeling in ischemic vascular disease.
-
SAR405: A Precision Vps34 Inhibitor Workflow
2026-08-24
SAR405 enables selective Vps34 perturbation for dissecting autophagy, vesicle trafficking, lysosome biology, and emerging nuclear PI3P functions. This workflow combines practical dosing guidance with orthogonal controls that help distinguish pathway-specific effects from nonspecific toxicity or assay artifacts.
-
AIBP-LRP2 Axis Restricts CXCR4+ Collateral Growth
2026-08-24
Zhu et al. identify an AIBP-LRP2-HDL-miR-223 pathway that limits the expansion of CXCR4+ stemlike capillary endothelial cells after ischemia. The study links lipid handling to collateral circulation and proposes that restoring CXCR4 activity could support revascularization, although the evidence remains primarily mechanistic and preclinical.
-
PLGA Nano-Adjuvant Enhances Mucosal Immunity in Chicks
2026-08-23
The reference study develops PEI-LSP-RA-PLGA, a double-layer PLGA nanoparticle adjuvant designed to combine sustained delivery, intestinal targeting, and immune regulation in chicks vaccinated against H9N2 avian influenza. Its reported increases in serum IgG and intestinal IgA, together with pathway-level evidence involving CCR9, CCR6, Toll-like receptor, NOD-like receptor, and IgA-production networks, support a mechanistic framework for coordinating systemic and mucosal immunity.
-
Amikacin Sulfate: NTM Research Guide
2026-08-22
Amikacin Sulfate is an aminoglycoside research compound with dose-dependent bactericidal activity against selected Mycobacterium avium complex and Staphylococcus aureus models. Its reported intracellular uptake and granuloma-directed distribution support research into targeted drug delivery of amikacin, while toxicity and assay-specific exposure limits remain important constraints.
-
X-Gal: Mechanism and Blue-White Screening
2026-08-21
X-Gal, also called 5-bromo-4-chloro-indolyl-β-D-galactopyranoside, is a chromogenic β-galactosidase substrate for visual clone selection. Its lacZα-dependent blue-white readout supports rapid molecular cloning decisions, while product specifications define its identity, solubility, purity, and storage requirements.
-
ATG4B Nuclear Translocation and AML DNA Repair
2026-08-20
The reference study identifies an unexpected mechanism connecting energy deficiency with genomic instability in acute myeloid leukemia: nuclear ATG4B binds PRMT1 and suppresses PRMT1-dependent MRE11 methylation. Across patient-derived, genetically induced, and xenograft models, ATG4B inhibition improved DNA damage responses, reduced malignant progression, and extended survival, providing a mechanistic framework for studying metabolic control of DNA repair.
-
CDK4, 4E-BP1, and Chemoproteomic Kinase Mapping
2026-08-20
Mitchell et al. developed PhAXA, a phosphosite-aware chemoproteomic workflow for identifying transient kinase–substrate interactions. The study assigned CDK4 as a regulator of 4E-BP1 phosphorylation, revealing a mechanism that sustains cap-dependent c-Myc translation and contributes to cooperation between CDK4/6 and mTORC1 inhibitors in breast cancer models.
-
Cyanin Chloride in a HaCaT Psoriasis Model
2026-08-19
A 2024 study examined cyanin chloride in chemical antioxidant assays, an LPS-stimulated macrophage system, and a cytokine-induced HaCaT model of psoriasis. Its main contribution was to connect reduced inflammatory signaling, STAT3 regulation, and improved epithelial barrier readouts while showing why these in vitro results should not be interpreted as clinical efficacy.
-
Mdivi-1: Translating DRP1 Biology into Better Models
2026-08-19
Mdivi-1 provides a practical way to interrogate DRP1-dependent mitochondrial fission, apoptosis, and inflammatory signaling. This translational guide connects mitochondrial dynamics research with ER stress and NLRP3 biology while emphasizing controls, assay design, and limits of pharmacological interpretation.
-
RA and Nutrient Restriction Initiate Meiosis in Mouse SSCs
2026-08-18
Zhang and Wang describe a culture strategy in which retinoic acid and nutrient restriction act synergistically to induce meiotic initiation in long-term cultured mouse spermatogonial stem cells. The method addresses a persistent in vitro limitation and provides a controlled platform for studying meiotic entry, germline biology, and future fertility-preservation approaches.
-
Phenylalanine Nanostructures Sensitize ICB
2026-08-18
The reference study presents metal-ion-chelating L-phenylalanine nanostructures as immunomodulatory materials that activate dendritic cells through coordinated potassium, calcium, NLRP3 inflammasome, and NF-κB signaling. Short-term starvation enhanced nanostructure uptake and tumor-specific cytotoxic T-cell responses, improving the activity of immune checkpoint blockade in breast and colorectal tumor models.
-
Safe DNA Gel Stain: From Gel Image to Genotype
2026-08-17
Safe DNA Gel Stain enables sensitive DNA and RNA gel stain workflows while supporting blue-light imaging and more deliberate genotype interpretation. This article connects stain selection to wheat gene-diversity assays, cloning decisions, and experimental reproducibility.
-
GDC-0994 for Reliable ERK1/2 Assays
2026-08-17
A scenario-based guide to using GDC-0994 (SKU B5817) in viability, proliferation, cytotoxicity, and ERK pathway studies. It explains assay design, stock preparation, interpretation of phospho-ERK results, zebrafish cholestasis applications, and practical criteria for selecting a reliable ERK1/2 inhibitor.